Clinical and dosimetric factors associated with a prolonged feeding tube requirement in patients treated with chemoradiotherapy (CRT) for head and neck cancers

被引:22
作者
Gokhale, A. S. [1 ]
McLaughlin, B. T. [2 ]
Flickinger, J. C. [1 ]
Beriwal, S. [1 ]
Heron, D. E. [1 ]
Ferris, R. L. [3 ]
Johnson, J. [3 ]
Gibson, M. K. [2 ]
Argiris, A. [2 ]
Smith, R. P. [1 ]
机构
[1] Univ Pittsburgh, Inst Canc, Dept Radiat Oncol, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Inst Canc, Div Hematol Oncol, Dept Med, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Inst Canc, Dept Otolaryngol, Pittsburgh, PA 15213 USA
关键词
chemoradiation; dysphagia; feeding tubes; head and neck cancer; quality of life; ADVANCED LARYNGEAL-CANCER; LOCALLY ADVANCED HEAD; QUALITY-OF-LIFE; INTENSITY-MODULATED RADIOTHERAPY; SQUAMOUS-CELL CARCINOMA; RADIATION-THERAPY; CONVENTIONAL RADIOTHERAPY; CONCOMITANT CHEMOTHERAPY; REDUCE DYSPHAGIA; CHEMORADIATION;
D O I
10.1093/annonc/mdp268
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Patients and methods: We retrospectively reviewed 80 patients treated with CRT for head and neck cancers. The pharyngeal constrictors (PCs), supraglottic larynx (SGL), and glottic larynx (GL) were contoured and the mean radiation doses and the volumes of each receiving > 40, 50, 60, and 70 Gy (V40, V50, V60, and V70) were determined. Results: A total of 33 of 80 patients required a FT either before or during the course of CRT. Fifteen patients required the FT for >= 6 months. On univariate analysis, significant factors associated with a prolonged FT requirement were mean PC dose, PC-V60, PC-V70, SGL dose, SGL-V70, and advanced T3-T4 disease. Multivariate analyses found both PC-V70 and T3-T4 disease as significant factors .The proportions of patients requiring a FT >= 6 months were 8% and 28% for treatment plans with PC-V70 < 30% and >= 30%, respectively. Conclusions: Increased radiation dose to the PCs is associated with a higher risk of a prolonged FT need. Dose sparing of the PC muscles may reduce this risk.
引用
收藏
页码:145 / 151
页数:7
相关论文
共 37 条
[11]   Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer [J].
Eisbruch, A ;
Lyden, T ;
Bradford, CR ;
Dawson, LA ;
Haxer, MJ ;
Miller, AE ;
Teknos, TN ;
Chepeha, DB ;
Hogikyan, ND ;
Terrell, JE ;
Wolf, GT .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (01) :23-28
[12]   Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer [J].
Eisbruch, A ;
Ten Haken, RK ;
Kim, HM ;
Marsh, LH ;
Ship, JA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (03) :577-587
[13]   Can IMRT or brachytherapy reduce dysphagia associated with chemoradiotherapy of head and neck cancer? The Michigan and Rotterdam experiences [J].
Eisbruch, Avraham ;
Levendag, Peter C. ;
Feng, Felix Y. ;
Teguh, David ;
Lyden, Teresa ;
Schmitz, Paul I. M. ;
Haxer, Marc ;
Noever, Inge ;
Chepeha, Douglas B. ;
Heijmen, Ben J. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (02) :S40-S42
[14]   Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: Early dose-effect relationships for the swallowing structures [J].
Feng, Felix Y. ;
Kim, Hyungjin M. ;
Lyden, Teresa H. ;
Haxer, Marc J. ;
Feng, Mary ;
Worden, Frank P. ;
Chepeha, Douglas B. ;
Eisbruch, Avraham .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (05) :1289-1298
[15]   Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer [J].
Forastiere, AA ;
Goepfert, H ;
Maor, M ;
Pajak, TF ;
Weber, R ;
Morrison, W ;
Glisson, B ;
Trotti, A ;
Ridge, JA ;
Chao, C ;
Peters, G ;
Lee, DJ ;
Leaf, A ;
Ensley, J ;
Cooper, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (22) :2091-2098
[16]   Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients:: Matched-pair comparison with conventional radiotherapy [J].
Graff, Pierre ;
Lapeyre, Michel ;
Desandes, Emnianuel ;
Ortholan, Cecile ;
Bensadoun, Rene-Jean ;
Alfonsi, Marc ;
Maingon, Philippe ;
Giraud, Philippe ;
Bourhis, Jean ;
Marchesi, Vincent ;
Mege, Alice ;
Peiffert, Didier .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (05) :1309-1317
[17]   Larynx preservation in pyriform sinus cancer: Preliminary results of a European organization for research and treatment of cancer phase III trial [J].
Lefebvre, JL ;
Chevalier, D ;
Luboinski, B ;
Kirkpatrick, A ;
Collette, L ;
Sahmoud, T .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (13) :890-899
[18]   Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: A dose-effect relationship [J].
Levendag, Peter C. ;
Teguh, David N. ;
Voet, Peter ;
van der Est, Henri ;
Noever, Inge ;
de Kruijf, Wilhelmus J. M. ;
Kolkman-Deurloo, Inger-Karine ;
Prevost, Jean-Briac ;
Poll, Johan ;
Schmitz, Paul I. M. ;
Heijmen, Ben J. .
RADIOTHERAPY AND ONCOLOGY, 2007, 85 (01) :64-73
[19]  
LEWIN JS, 1997, INT J RAD ONCOL BI S, V69, pS86
[20]   Sensorineural hearing loss after radiotherapy and chemoradiotherapy: A single, blinded, randomized study [J].
Low, WK ;
Toh, ST ;
Wee, J ;
Fook-Chong, SMC ;
Wang, DY .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (12) :1904-1909